CYTK Q2 2017 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-47.4% YoY

Gross Profit

-$17M-548.8% margin

Operating Income

-$25M-825.2% margin

Net Income

-$29M-952.5% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

-26.5%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$32M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$341M

Total Liabilities

$166M

Stockholders' Equity

$175M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$6M	-47.4%
Gross Profit	-$17M	-$4M	-327.3%
Operating Income	-$25M	-$11M	-128.8%
Net Income	-$29M	-$12M	-150.5%